• ABOUT
        • MISSION/HISTORY
        • DIRECTORS/STAFF
        • SUPPORT
        • INTERNSHIPS
        • FINANCIAL INFORMATION
        • JOBS
        • CONTACT US
  • WASTEWATCHER
  • MEDIA
        • COMMENTARY
        • PRESS RELEASES
        • VIDEOS
  • ISSUES
    • CONGRESSIONAL PIG BOOK
      • EARMARK DATABASE
      • PRIME CUTS
      • ISSUE BRIEFS
      • AGENCY COMMENTS
    • DEFENSE
      • AVIATION & SPACE
      • F-35 JOINT STRIKE FIGHTER
      • PROCUREMENT
    • INNOVATION & TECHNOLOGY POLICY CENTER
      • ANTITRUST
      • ARTIFICIAL INTELLIGENCE
      • BIOPHARMACEUTICALS
      • INTELLECTUAL PROPERTY
      • PRIVACY
      • TECHNOLOGY AND INNOVATION
      • TELECOMMUNICATIONS
    • GENERAL WASTE
      • AGRICULTURE REFORM
      • POSTAL SERVICE
      • TAXES
      • TRANSPORTATION
    • HEALTH AND SCIENCE
      • PRICE CONTROLS
      • GOVERNMENT RUN HEALTHCARE
      • 340B DRUG DISCOUNT PROGRAM
      • PHARMACY BENEFIT MANAGERS
      • TOBACCO HARM REDUCTION
    • STATE ISSUES
  • ITPC
        • ANTITRUST
        • ARTIFICIAL INTELLIGENCE
        • BIOPHARMACEUTICALS
        • INTELLECTUAL PROPERTY
        • PRIVACY
        • TECHNOLOGY AND INNOVATION
        • TELECOMMUNICATIONS
  • CCAGW
DONATE
Facebook X-twitter Icon-instagram-1 Icon-youtube

Intellectual Property

Thomas Schatz

Biden’s Budget and the SMART Prices Act Will Devastate Drug Development

Thomas Schatz June 24, 2023
Recognizing Women’s Medical Innovations on World IP Day
Christina Smith

Recognizing Women’s Medical Innovations on World IP Day

Christina Smith April 26, 2023
Deborah Collier

Celebrating Creative Women on World IP Day

Deborah Collier April 26, 2023
The Inflation Reduction Act Is a Fiscal Disaster
Thomas Schatz

The Inflation Reduction Act Is a Fiscal Disaster

Thomas Schatz August 2, 2022
The Senate Must Reject Price Controls on Pharmaceuticals
Thomas Schatz

The Senate Must Reject Price Controls on Pharmaceuticals

Thomas Schatz July 7, 2022
Christina Smith

Sen. Elizabeth Warren Wants the Government to Steal IP and Stifle Future Pharmaceutical Innovation

Christina Smith April 27, 2022
« Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Next »
  • ANTITRUST
  • ARTIFICIAL INTELLIGENCE
  • BIOPHARMACEUTICALS
  • INTELLECTUAL PROPERTY
  • PRIVACY
  • TECHNOLOGY AND INNOVATION
  • TELECOMMUNICATIONS
  • ANTITRUST
  • ARTIFICIAL INTELLIGENCE
  • BIOPHARMACEUTICALS
  • INTELLECTUAL PROPERTY
  • PRIVACY
  • TECHNOLOGY AND INNOVATION
  • TELECOMMUNICATIONS


    Citizens Against Government Waste works to eliminate waste, fraud, abuse, and mismanagement in government through research and public education.

    • ABOUT
    • WASTEWATCHER
    • MEDIA CENTER
    • ISSUES
    • ITPC
    • CCAGW
    • 1-800-USA-DEBT ®
    • MEDIA@CAGW.ORG
    • 317 MASSACHUSETTS AVENUE, N.E.
      SUITE 300
      WASHINGTON, D.C. 20002

    © Citizens Against Government Waste